Ovation Bio Technologies Pvt Ltd - Company Profile

8/2/2019 Ovation Bio Technologies Pvt Ltd - Company Profile

http://slidepdf.com/reader/full/ovation-bio-technologies-pvt-ltd-company-profile 1/18

Ovation Biotechnologies Pvt.

Ltd.

February 2012



2

Contents

Executive Summary

Factsheet

Offices &

Centres

Key Products and Services

Key People

SWOT Analysis

Financial Profile

Industry Analysis

Competitive Landscape

Competitive Benchmarking

Appendix

Ovation Biotechnologies Pvt.

Ltd.



3

Executive Summary

Company Description

• Ovation Biotechnologies Pvt. Ltd. is headquartered in A and engages in B, C and D

• The company is T certified and its products are P


• It manufactures medical equipments under various segments such as T, M, O and V

SWOT Analysis

• Strength 1 is one of the major strengths of the company; however weakness 1 is one of the key areas of

concern

• The company

can

reap

significant

benefits

owing

to

opportunity

1 while

threat

1

may

have

an

adverse

affect on the strategic initiatives and growth prospects of the organization

Financial Profile

• Ovation Biotechnologies Pvt. Ltd. generated total revenues of INR A mn in the fiscal year (FY) 20‐‐

registering a y‐o‐y decrease of x per cent. It earned a net profit of INR N mn in FY 20‐‐ as compared to a net

profit of P mn in FY 20‐‐

• The financial profile of the company includes the balance sheet, profit and loss a/c and the key ratios

depicting the

key

financial

figures

for

FY

20

‐‐, 20

‐‐, 20

‐‐and

20

‐‐, giving

an

insight

into

the

company's

financial performance

Industry Analysis

• Medical Equipments market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per

cent to reach INR B bn in FY 20‐‐

• The Medical Equipments market is classified into segments such as P, Q, R and S

• The Surgical

Instruments

market

in

India

is

estimated

at

INR

A

bn

in

FY

20

‐‐and

is

expected

to

grow

at

a

CAGR of x per cent to reach INR B bn by FY 20‐‐

• The key drivers are A, B, C and D

Competitive Landscape

• Key competitors for the company can be enlisted as: Competitor 1 and Competitor 2



4

S A M P L E

FactsheetBasic Information

• Ovation Biotechnologies Pvt. Ltd. (Ovation) is headquartered in

A and engages in B, C and D

• The company is T certified and its products are M

• It manufactures products under segments such as:

• T

• I

• S

• G

• It manufactures products such as S, P, Y, L, A, F, C, Z, J, O, etc.

Brief Description

‐‐Auditor

Industry ‐‐

Corporate Address

‐‐

Tel No. ‐‐

Fax No. ‐‐

Website ‐‐

Year Founded ‐‐

Year of Incorporation ‐‐

Ownership ‐‐

Revenue‐‐

Fiscal Year End ‐‐

Key Competitors ‐‐

Source:

Brief History

• 20‐‐:



5

Offices & Centres – India

Note:

Source:

S A M P L E

Headquarters



SA M P L E

Ovation

Biotechnologies

Pvt.

Ltd.

Product 1

The company generates revenue through its products which include:

Source:

• ‐‐

Product 3Product 2

•‐‐ • ‐‐

Product 4

• ‐‐




S A M P L E

Key PeopleKey People Ownership Structure

Source:

Shareholding Pattern

Total Paid‐up Capital INR A

Total Number of shareholders ‐

Name No. of

Shares

Held

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

‐‐ ‐‐

Note:

x%

P

Name DesignationAge

(years)

Date of

Appointment

‐‐ ‐‐ ‐‐ ‐‐

‐‐ ‐‐ ‐‐ ‐‐

‐‐ ‐‐ ‐‐ ‐‐

‐‐ ‐‐ ‐‐ ‐‐

Shareholders of the Company



SWOT Analysis (1/2)

Source:

Internal

Factors

• Strength 1

• Strength 2

• Weakness 1

Strengths Weakness

S A M P L E



SWOT Analysis (2/2)

Source:

External

Factors

• Opportunity 1

• Opportunity 2

• Threat 1

• Threat 2

Opportunities Threats

S A M P L E



S A M P L E

Financial Profile

Particulars 2008 2009 2010 2011

Operating

Income‐ ‐ ‐ ‐

Total

Income‐ ‐ ‐ ‐

Expenditure

(below)‐ ‐ ‐ ‐

Total

Expenditure‐ ‐ ‐ ‐

Profit/(Loss)

after Tax‐ ‐ ‐ ‐

0

2

4

6

8

10

D

C

INR mn

E

20‐‐

G

20‐‐

H

20‐‐

FB

20‐‐

A

Financial Snapshot Profit & Loss Statement

Note:

Financial Summary

Net

Profit/Loss

after

tax

Total Income

• Analysis Point 1


• Analysis Point

3

Source:



SAMPLE Ratio AnalysisKey Ratios

Source:Note:

Key Ratio Analysis

Improved Decline






Particulars

y‐o‐y

change

(2011‐10)

2011 2010 2009 2008

Profitability Ratios ‐ ‐ ‐ ‐ ‐

Net Margin ‐ ‐ ‐ ‐ ‐

Return on Equity ‐ ‐ ‐ ‐ ‐

Return on

Working

Capital

‐ ‐ ‐ ‐ ‐

Return on Assets ‐ ‐ ‐ ‐ ‐

Return on Fixed Assets ‐ ‐ ‐ ‐ ‐

Liquidity Ratios ‐ ‐ ‐ ‐ ‐

Current Ratio

‐ ‐ ‐ ‐ ‐

Cash Ratio ‐ ‐ ‐ ‐ ‐

Efficiency Ratios ‐ ‐ ‐ ‐ ‐

Fixed Asset Turnover ‐ ‐ ‐ ‐ ‐

Asset Turnover

‐ ‐ ‐ ‐ ‐

Current Asset Turnover ‐ ‐ ‐ ‐ ‐

Working Capital Turnover ‐ ‐ ‐ ‐ ‐

Capital Employed Turnover ‐ ‐ ‐ ‐ ‐



SA M P L E

Annual Financial Ratios

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

2008 2009 2010 2011

0

5

10

15

20

2008 2009 2010 2011

Profitability Ratios

0

5

10

15

20

25

30

2008 2009 2010 2011

0

20

40

60

80

2008 2009 2010 2011

Source:



S A M P L E

Industry AnalysisMedical Equipment Industry – Overview

• The Medical Equipment market is estimated at INR A bn in FY

20‐‐ and expected to grow at a CAGR of x per cent to reach INR B

bn by

FY

20

‐‐

• This market can be classified into segments such as C, D, E and F

• Indian medical equipment market imports y per cent of its

medical equipments from countries such as M, N, O, P

• Major trends observed in the medical equipment market are:

Trend 1

Trend 2

Trend 3

Trend 4

Trend 5

• Some of the key drivers of the medical equipment market are:

Driver 1

Driver 2

Driver 3

Driver 4

Driver 5

• Some of the Government initiatives towards the Medical

equipment market were:

Point 1

Point 2

0

20

40

60

80

100

INR bn

x%

20‐‐e

G

20‐‐e

F

20‐‐e

E

20‐‐e

D

20‐‐e

C

20‐‐

B

20‐‐

A

Market Size & Growth (20‐‐ ‐20‐‐e)

Market Segmentation

(FY

20

‐‐)

a%

d%

c%b% P

ON

M

Source:



SA M P L

E Industry AnalysisSurgical Instruments Market – Overview Market Size & Growth (20‐‐ ‐20‐‐e)

Source:

Import ‐ Export Pattern of Major Surgical

Instruments

• The Surgical Instruments market in India is estimated at INR A bn

in FY

20

‐‐and

is

expected

to

grow

at

a

CAGR

of

x

per

cent

to

reach INR B bn by FY 20—

• Surgical Instruments is a part of the X

• Some

of

the

key

drivers

of

the

surgical

instruments

market

are:

‐‐

‐‐

‐‐

‐‐

• Some of the major trends are:

A

B

C

49%12%

0

5

10

15

20

25

20‐‐

Q

20‐‐

P

INR bn

R

x%

20‐‐

e

U

20‐‐

e

T

20‐‐

e

S

20‐‐

e

0

1,000

2,000

3,000 F

E

20-- 20--

H

INR mn

G

20--

D

C

20--

B

A

ExportsImports

‐‐‐‐

‐‐‐‐

‐‐‐‐

‐‐‐‐

‐‐‐‐

‐‐

HS Code Description

‐‐

HS Code



Competitive Landscape (1/2)

Company Name Description

Company 1 • ‐‐

•‐‐

• ‐‐

Company 2 ‐‐

‐‐

‐‐

Source:

SA M P L E



Competitive Landscape (2/2)Competitive Scenario

Company

Name Company A Company B Company C

Financial Information (INR mn – FY 2010)

Total Revenue ‐‐ ‐‐ ‐‐

Net Profit/(loss) ‐‐ ‐‐ ‐‐

Major Market

Segmentation

(Medical

Equipments)

Surgical Instruments

Sutures \Suture

Needles

Cannulas

Forceps

Scissors

Retractors

Catheters

Blades

Knives

Scalpel

Offered Not Offered Source: H: High; L: Low; M: Medium

SAMPLE

/



17

SA M P L E

Competitive Benchmarking (1/2)

0.0

0.2

0.4

0.6

0.8

1.0

1.2

%

Y

B

X

A

M

0

1

2

3

4

5

6

Y

D

X

C

% N





Key Financial Ratios – FY 2011 (1/2)

Source:

h k f h i



18

Thank you for the attention

www.netscribes.com

About Netscribes

Netscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment

& business

research,

business

&

corporate

intelligence,

content

‐management

services,

and

knowledge

‐software

services.

At

its

core

lies

a

true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and

growth objectives.

Ovation Biotechnologies Pvt. Ltd. is a part of Netscribes’ Healthcare Company ProfileSeries.For more detailed information or customized research requirements please contact:

This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt. Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes (India) Pvt. Ltd. and no part may be reproduced without prior written permission.

Jitendra PunjabiPhone: +91 33 4064 6215

E‐Mail: [email protected]

Documents

Ovation Bio Technologies Pvt Ltd - Company Profile